Zealand Pharma A/S (ZLDPF)
47.64
0.00 (0.00%)
USD |
OTCM |
Sep 04, 16:00
Zealand Pharma SG&A Expense (TTM) : 78.53M for June 30, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 78.53M |
| March 31, 2026 | 77.27M |
| December 31, 2025 | 75.49M |
| September 30, 2025 | 83.21M |
| June 30, 2025 | 67.14M |
| March 31, 2025 | 62.01M |
| December 31, 2024 | 58.48M |
| September 30, 2024 | 45.64M |
| June 30, 2024 | 39.08M |
| March 31, 2024 | 35.51M |
| December 31, 2023 | 31.33M |
| September 30, 2023 | 30.89M |
| June 30, 2023 | 31.78M |
| March 31, 2023 | 35.24M |
| December 31, 2022 | 38.21M |
| September 30, 2022 | 39.79M |
| June 30, 2022 | 43.27M |
| March 31, 2022 | 58.69M |
| December 31, 2021 | 70.25M |
| September 30, 2021 | 92.68M |
| June 30, 2021 | 102.72M |
| March 31, 2021 | 93.52M |
| December 31, 2020 | 75.90M |
| September 30, 2020 | 45.62M |
| June 30, 2020 | 26.34M |
| Date | Value |
|---|---|
| March 31, 2020 | 11.67M |
| December 31, 2019 | 10.18M |
| September 30, 2019 | 9.754M |
| June 30, 2019 | 8.972M |
| March 31, 2019 | 7.183M |
| December 31, 2018 | 6.305M |
| September 30, 2018 | 6.865M |
| June 30, 2018 | 6.513M |
| March 31, 2018 | 7.131M |
| December 31, 2017 | 7.227M |
| September 30, 2017 | 7.755M |
| June 30, 2017 | 7.283M |
| March 31, 2017 | 8.218M |
| December 31, 2016 | 7.912M |
| September 30, 2016 | 7.214M |
| June 30, 2016 | 7.761M |
| March 31, 2016 | 6.595M |
| December 31, 2015 | 6.613M |
| September 30, 2015 | 7.407M |
| June 30, 2015 | 7.102M |
| March 31, 2015 | 6.64M |
| December 31, 2014 | 6.977M |
| September 30, 2014 | 5.692M |
| June 30, 2014 | 5.997M |
| March 31, 2014 | 6.310M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Genmab A/S | 726.50M |
| Ascendis Pharma A/S | 662.10M |
| Bavarian Nordic A/S | 218.74M |
| Evaxion AS | 4.527M |
| Novo Nordisk A/S | 10.12B |